Thus, 5-LOX inhibitors could be potential therapeutics targeted to relief the neuropathic pain-associated symptoms via inhibiting the production of leukotrienes (LTs) which are essential inflammatory mediators in the pathophysiology of neuropathy (Masamichi et al., 2009). This evidence concerns the gene ALOX5 and neuropathy.